Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Tilray Brands, Inc. (TLRY) - free report >>
Amplify Seymour Cannabis ETF (CNBS) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tilray Brands, Inc. (TLRY) - free report >>
Amplify Seymour Cannabis ETF (CNBS) - free report >>
Image: Bigstock
Cannabis Stocks & ETFs: Can the Recent Surge Continue?
In this episode of ETF Spotlight, I speak with Tim Seymour, founder and CIO of Seymour Asset Management and co-host of CNBC's Fast Money, about broader markets and cannabis investing.
Cannabis stocks soared late last month after the Department of Health and Human Services asked the DEA to review its classification of cannabis. It is currently a Schedule I drug, along with heroin and LSD. The new designation would put it in the same group as anabolic steroids, testosterone, and ketamine.
Industry participants and investors were earlier hopeful for a more rapid path to full federal legalization, but not much progress has been made so far.
Late last week, it was reported that the Senate banking committee is expected to hold a markup session for the SAFE Banking Act, which would allow cannabis companies to use major financial and banking institutions.
We also discuss the investment case for cannabis, as its acceptance, use, and sales are rising steadily since states continue to remove restrictions on its use.
The Amplify Seymour Cannabis ETF (CNBS - Free Report) is actively managed by Tim, who has been an early-stage investor and industry expert. Green Thumb Industries Inc. (GTBIF - Free Report) , Curaleaf Holdings (CURLF - Free Report) and Tilray (TLRY - Free Report) are its top holdings.
Tune in to the podcast to learn more.
Make sure to be on the lookout for the next edition of ETF Spotlight and also make sure to subscribe! If you have any comments or questions, please email podcast@zacks.com.